TheraRadar
← Back
Data updated: Mar 29, 2026

PERRIGO R AND D

GastroenterologyInfectious DiseaseCardiovascular
Generics

PERRIGO R AND D is a generic drug manufacturer focused on Gastroenterology, Infectious Disease, Cardiovascular.

2005
Since
26
Drugs
-
Trials
222
Approved (2yr)

Key Drugs

NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE
diphenhydramine hydrochloride
· 2018
IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE
ibuprofen
· 2014
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE
dextromethorphan hydrobromide
· 2015

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

NICOTINE POLACRILEX 2026-02-05
Labeling
CETIRIZINE HYDROCHLORIDE ALLERGY 2026-01-30
Labeling
ATORVASTATIN CALCIUM 2026-01-22
Manufacturing (CMC)
LEVOCETIRIZINE DIHYDROCHLORIDE 2026-01-07
Labeling
ATORVASTATIN CALCIUM 2025-12-31
Labeling
LOPERAMIDE HYDROCHLORIDE 2025-12-29
OMEPRAZOLE AND SODIUM BICARBONATE 2025-12-10
CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF 2025-11-25
Manufacturing (CMC)
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Gastroenterology 50%
3 drugs
Infectious Disease 33%
2 drugs
Cardiovascular 17%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

APOTHECON specialty
Infectious Disease, Cardiovascular, Gastroenterology
Pfizer big-pharma
Infectious Disease, Gastroenterology
WAYLIS THERAP big-pharma
Cardiovascular, Infectious Disease, Gastroenterology
Merck big-pharma
Infectious Disease, Cardiovascular
WARNER CHILCOTT LLC specialty
Cardiovascular, Gastroenterology, Infectious Disease